Filing Details

Accession Number:
0001144204-18-040247
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-26 19:11:02
Reporting Period:
2018-07-24
Accepted Time:
2018-07-26 19:11:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566044 Menlo Therapeutics Inc. MNLO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1340886 J David Collier C/O Presidio Partners 2007 Gp, L.p.
655 Montgomery Street, Suite 6-161
San Francisco CA 94111
No No No Yes
1405712 Presidio Partners 2007, L.p. C/O Presidio Partners 2007 Gp, L.p.
655 Montgomery Street, Suite 6-161
San Francisco CA 94111
No No No Yes
1405972 Presidio Partners 2007 (Parallel), L.p. C/O Presidio Partners 2007 Gp, L.p.
655 Montgomery Street, Suite 6-161
San Francisco CA 94111
No No No Yes
1420406 F James Watson C/O Presidio Partners 2007 Gp, L.p.
655 Montgomery Street, Suite 6-161
San Francisco CA 94111
No No No Yes
1425386 Presidio Partners 2007 Gp, L.p. 655 Montgomery Street, Suite 6-161,
San Francisco CA 94111
No No No Yes
1425394 A. Faysal Sohail C/O Presidio Partners 2007 Gp, L.p.
655 Montgomery Street, Suite 6-161
San Francisco CA 94111
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-24 487,500 $7.65 1,907,568 No 4 S Indirect By Presidio Partners 2007, L.P.
Common Stock Disposition 2018-07-24 12,500 $7.65 48,910 No 4 S Indirect By Presidio Partners 2007 (Parallel), L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Presidio Partners 2007, L.P.
No 4 S Indirect By Presidio Partners 2007 (Parallel), L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 152,062 Indirect By David J. Collier
Footnotes
  1. Securities directly held by Presidio Partners 2007, L.P. ("Presidio Partners"). Presidio Partners 2007 GP, L.P. ("Presidio GP") is the sole general partner of Presidio Partners. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio GP, and may be deemed to have voting control and investment power over the securities held by Presidio Partners, but disclaim beneficial ownership of the securities held by Presidio Partners, except to the extent of their pecuniary interest therein.
  2. Securities directly held by Presidio Partners 2007 (Parallel), L.P. ("Presidio Parallel"). Presidio GP is the sole general partner of Presidio Parallel. David Collier, M.D., James Watson and Faysal Sohail are the general partners of Presidio Parallel, and may be deemed to have voting control and investment power over the securities held by Presidio Parallel, but disclaim beneficial ownership of the securities held by Presidio Parallel, except to the extent of their pecuniary interest therein.
  3. Securities directly held by David J. Collier, M.D.